MTOR and small cell lung carcinoma: Genomic and transcriptomic analyses found that PI3K/AKT was upregulated in chemoresistant SCLC cell lines and patient samples [161] and that mTOR signaling was upregulated in a panel of chemoresistant PDXs [149].